Ellington Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-16,300
| Closed | -$909K | – | 74 |
|
|
2020
Q1 | $909K | Buy |
16,300
+1,200
| +8% | +$66.9K | 0.21% | 119 |
|
|
2019
Q4 | $969K | Buy |
15,100
+8,900
| +144% | +$571K | 0.21% | 71 |
|
|
2019
Q3 | $314K | Sell |
6,200
-2,400
| -28% | -$122K | 0.06% | 331 |
|
|
2019
Q2 | $390K | Sell |
8,600
-500
| -5% | -$22.7K | 0.07% | 276 |
|
|
2019
Q1 | $434K | Buy |
+9,100
| New | +$434K | 0.08% | 243 |
|
|
2017
Q3 | – | Sell |
-5,300
| Closed | -$295K | – | 637 |
|
|
2017
Q2 | $295K | Buy |
+5,300
| New | +$295K | 0.04% | 393 |
|
|
2017
Q1 | – | Sell |
-17,200
| Closed | -$1.01M | – | 687 |
|
|
2016
Q4 | $1.01M | Buy |
+17,200
| New | +$1.01M | 0.15% | 58 |
|
|
2014
Q3 | – | Sell |
-12,500
| Closed | -$606K | – | 310 |
|
|
2014
Q2 | $606K | Buy |
+12,500
| New | +$606K | 0.28% | 73 |
|